• $2.7M
    Market Cap
  • -86.17%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
N/A
N/A
250,000
+563.96%
37,653
-71.37%
131,521
+51.20%
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
0
-100.00%
250,000
+563.96%
37,653
-71.37%
131,521
+51.20%
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-2.4M
-41.85%
-4.1M
-73.44%
-15.5M
+53.79%
-10.1M
-4.85%
Depreciation and Amortization Expense
N/A
N/A
N/A
N/A
27,391
-38.68%
44,667
+8.32%
Total Operating Expenses
9.4M
-11.33%
10.6M
-49.58%
20.9M
+43.96%
14.5M
-8.27%
Operating Profit
-9.4M
-11.33%
-10.6M
-49.49%
-20.9M
+45.02%
-14.4M
-8.59%
Interest Income
182,229
+297.04%
45,897
-78.19%
210,394
+54.82%
135,900
+79.18%
Interest Expense
N/A
N/A
N/A
N/A
-30,591
+102.55%
-15,103
-4.14%
Interest Income and Expense and Net
182,229
+297.04%
45,897
-74.47%
179,803
+48.85%
120,797
+101.02%
Total Nonoperating Income and Expense
-616,894
+6,676.82%
-9,103
-103.65%
249,166
+95.83%
127,239
+114.19%
Income before Taxes
-10.0M
-5.57%
-10.6M
-48.84%
-20.7M
+44.56%
-14.3M
-9.06%
Income Taxes
-136,910
-90.28%
-1.4M
-75.68%
-5.8M
-255.90%
3.7M
+326.55%
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
N/A
N/A
-10.6M
-48.84%
-20.7M
+44.56%
-14.3M
-9.06%
Net Income from Continuing Operations Applicable to Common
-10.0M
-5.57%
-10.6M
-48.84%
-20.7M
+44.56%
-14.3M
-9.06%
Basic EPS and Net Income
-4.56
+185.00%
-1.60
-82.57%
-9.18
+29.11%
-7.11
+4,978.57%
Diluted EPS and Net Income
-4.56
+185.00%
-1.60
-82.57%
-9.18
+29.11%
-7.11
+4,978.57%
Basic Weighted Average Shares
2.2M
-67.43%
6.6M
+194.35%
2.2M
+11.97%
2.0M
-98.22%
Diluted Weighted Average Shares
2.2M
-67.43%
6.6M
+194.35%
2.2M
+11.97%
2.0M
-98.22%
Balance Sheet
Cash and Cash Equivalents
4.4M
+408.73%
864,840
-75.17%
3.5M
-69.51%
11.4M
-58.09%
Short-Term Investments
4.0M
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
8.4M
+871.25%
864,840
-75.17%
3.5M
-69.51%
11.4M
-58.09%
Total Current Assets
10.1M
+583.71%
1.5M
-61.91%
3.9M
-72.95%
14.3M
-48.43%
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
1.4M
-16.20%
Property and Plant and Equipment and Net
N/A
N/A
N/A
N/A
0
-100.00%
121,062
+164.86%
Total Long-Term Assets
N/A
N/A
N/A
N/A
0
-100.00%
121,062
+164.86%
Total Assets
10.1M
+583.71%
1.5M
-70.35%
5.0M
-66.35%
14.8M
-47.72%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
3.0M
+813.16%
328,528
+5.06%
312,703
+16.84%
267,640
-11.79%
Total Current Liabilities
1.6M
-7.44%
1.7M
-6.33%
1.8M
+12.65%
1.6M
+10.45%
Total Long-Term Debt
N/A
N/A
N/A
N/A
312,703
N/A
N/A
N/A
Total Long-Term Liabilities
N/A
N/A
N/A
N/A
9,811
-93.56%
152,439
-49.11%
Total Liabilities
1.8M
+6.05%
1.7M
-6.33%
1.8M
+2.83%
1.7M
+0.23%
Retained Earnings
-226.6M
+4.54%
-216.8M
+5.12%
-206.2M
+11.13%
-185.6M
+8.34%
Total Stockholders Equity
N/A
N/A
-211,885
-106.69%
3.2M
-75.65%
13.0M
-50.88%
Total Shares Outstanding
4.3M
-66.02%
12.6M
+308.03%
3.1M
+52.16%
2.0M
-98.26%
Cash Flow
Cash from Operating Activities
-9.2M
+7.55%
-8.6M
+17.92%
-7.3M
-52.12%
-15.2M
+13.05%
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
127,519
+190.63%
Cash from Investing Activities
N/A
N/A
N/A
N/A
-936,284
+710.50%
-115,519
+163.29%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
16.8M
+180.68%
6.0M
+2,006.07%
283,880
+157.36%
-494,916
-102.14%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
-4,223.53%
-92.39%
-55,519.89%
+406.54%
-10,960.70%
-39.54%
Return on Assets
N/A
N/A
-328.26%
+56.73%
-209.44%
+215.07%
-66.47%
-0.76%
Return on Equity
N/A
N/A
-714.95%
+179.97%
-255.36%
+252.94%
-72.35%
-0.23%
Revenue Growth
N/A
N/A
563.96%
+890.18%
-71.37%
-239.41%
51.20%
N/A
Current Ratio
6.46
+638.71%
0.87
-59.34%
2.15
-75.98%
8.95
-53.31%
Cash Ratio
2.82
+449.69%
0.51
-73.50%
1.94
-72.94%
7.16
-62.06%
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
0.20
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
0.13
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow